Neuroimaging Findings in a Patient with Anti-IgLON5 Disease: Cerebrospinal Fluid Dynamics Abnormalities

被引:6
|
作者
Urso, Daniele [1 ,2 ]
De Blasi, Roberto [3 ]
Anastasia, Antonio [3 ]
Gnoni, Valentina [1 ,2 ]
Rizzo, Valentina [3 ]
Nigro, Salvatore [1 ]
Tafuri, Benedetta [1 ,4 ]
Iacolucci, Carlo Maria [1 ]
Zecca, Chiara [1 ]
Dell'Abate, Maria Teresa [1 ]
Andreetta, Francesca [5 ]
Logroscino, Giancarlo [1 ,4 ]
机构
[1] Univ Bari Aldo Moro, Pia Fdn Cardinale G Panico, Ctr Neurodegenerat Dis & Aging Brain, Dept Clin Res Neurol, I-73039 Tricase, Italy
[2] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Neurosci, De Crespigny Pk, London SE5 8AF, England
[3] Pia Fdn Culto & Relig Card G Panico, Dept Diagnost Imaging, I-73039 Tricase, Italy
[4] Univ Bari Aldo Moro, Dept Basic Med Neurosci & Sense Organs, I-70124 Bari, Italy
[5] Fdn IRCCS Ist Neurol Carlo Besta, Neurol Neuroimmunol & Neuromuscular Dis Unit 4, I-20133 Milan, Italy
关键词
anti-IgLON5; disease; neuroimaging; PSP; MRI; nuclear medicine; cerebrospinal fluid dynamics;
D O I
10.3390/diagnostics12040849
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Anti-IgLON5 disease is a recently described autoimmune neurodegenerative disorder characterized by insidious onset, slow progression and a variety of neurological features. Neuroimaging in most patients with anti-IgLON5 disease is normal or shows nonspecific findings. Here, we report a case of anti-IgLON5 disease presenting with parkinsonism, falls, sleep problems with severe nocturnal dyspnea attacks, dysphagia, and dysautonomia. Imaging findings were initially suggestive of progressive supranuclear palsy. An altered cerebrospinal fluid dynamic was found on an MRI as well as high-convexity hyperperfusion on a brain SPECT. Further case descriptions with neuroimaging are required to characterize cerebral and cerebrospinal fluid dynamics abnormalities in this rare condition.
引用
收藏
页数:4
相关论文
共 50 条
  • [21] Patient With Rigidity and Fasciculations Steroid-Responsive Presentation of Anti-IgLON5 Disease
    Bellucci, Margherita
    Castellano, Chiara
    Marinelli, Lucio
    Garbarino, Lucia
    Gastaldi, Matteo
    Franciotta, Diego
    Benedetti, Luana
    NEUROLOGY, 2024, 102 (03)
  • [22] A life-threatening case of Anti-IgLON5 disease
    Filidei, M.
    Tambasco, N.
    Paoletti, F. Paolini
    Simoni, S.
    Brahimi, E.
    Cappelletti, G.
    Nigro, P.
    Calabresi, P.
    MOVEMENT DISORDERS, 2019, 34 : S124 - S124
  • [23] Clinical presentations and antibody mechanisms in anti-IgLON5 disease
    Gaig, C.
    Sabater, L.
    REVUE NEUROLOGIQUE, 2024, 180 (09) : 940 - 949
  • [24] Response to immunotherapy in anti-IgLON5 disease: A systematic review
    Cabezudo-Garcia, Pablo
    Mena-Vazquez, Natalia
    Estivill Torrus, Guillermo
    Serrano-Castro, Pedro
    ACTA NEUROLOGICA SCANDINAVICA, 2020, 141 (04): : 263 - 270
  • [25] Anti-IgLON5 disease: a novel topic beyond neuroimmunology
    Yi-ZongHeng Zhang
    You Ni
    Yi-Ning Gao
    Ding-Ding Shen
    Lu He
    Dou Yin
    Huan-Yu Meng
    Qin-Ming Zhou
    Ji Hu
    Sheng Chen
    Neural Regeneration Research, 2023, 18 (05) : 1017 - 1022
  • [26] Anti-IgLON5 disease with distinctive brain MRI findings responding to immunotherapy A case report
    Pi, Yan
    Zhang, Li-li
    Li, Jing-cheng
    MEDICINE, 2021, 100 (04)
  • [27] Anti-IgLON5 disease with persistent headache: A case report
    Sui, Yihang
    Wu, Yong
    Yuan, Ping
    Lv, Zhiyu
    ASIAN JOURNAL OF SURGERY, 2024, 47 (02) : 1155 - 1156
  • [28] Proximal myopathy as a prominent feature of anti-IgLON5 disease
    Crijnen, Y.
    Franken, S.
    Endmayr, V.
    Van der Beek, N.
    Gelpi, E.
    Shigemoto, R.
    Strobel, T.
    Van Steenhoven, R.
    Paunovic, M.
    De Vries, J.
    Kerstens, J.
    Brenner, J.
    Bastiaansen, A.
    Louter, M.
    Verbeek, M.
    Roelen, D.
    Smitt, P. Sillevis
    Hoftberger, R.
    Titulaer, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 387 - 387
  • [29] Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease
    Gaig, Carles
    Compta, Yaroslau
    Heidbreder, Anna
    Marti, Maria J.
    Titulaer, Maarten J.
    Crijnen, Yvette
    Hoegl, Birgit
    Lewerenz, Jan
    Erro, Maria Elena
    Garcia-Monco, Juan Carlos
    Nigro, Pasquale
    Tambasco, Nicola
    Patalong-Ogiewa, Maja
    Erdler, Marcus
    Macher, Stefan
    Berger-Sieczkowski, Evelyn
    Hoeftberger, Romana
    Geis, Christian
    Hutterer, Markus
    Milan-Tomas, Angela
    Martin-Bastida, Antonio
    Manzanares, Lydia Lopez
    Quintas, Sonia
    Hoeglinger, Guenter U.
    Moehn, Nora
    Schoeberl, Florian
    Thaler, Franziska S.
    Asioli, Gian Maria
    Provini, Federica
    Plazzi, Giuseppe
    Berganzo, Koldo
    Blaabjerg, Morten
    Brueggemann, Norbert
    Farias, Tarsis
    Ng, Chen Fei
    Giordana, Caroline
    Herrero-San Martin, Alejandro
    Huebra, Lucio
    Kotschet, Katya
    Liendl, Herburg
    Montojo, Teresa
    Morata, Carlos
    Perez, Jesus Perez
    Puertas, Inmaculada
    Seifert-Held, Thomas
    Seitz, Caspar
    Simabukuro, Mateus Mistieri
    Tellez, Nieves
    Villacieros-Alvarez, Javier
    Willekens, Barbara
    NEUROLOGY, 2021, 97 (14) : E1367 - E1381
  • [30] Development of a Composite Score for the Clinical Assessment of Anti-IgLON5 Disease
    Gaig, Carles
    Grueter, Thomas
    Heidbreder, Anna
    Sabater, Lidia
    Iranzo, Alex
    Santamaria, Joan
    Leypoldt, Frank
    Dalmau, Josep O.
    Ayzenberg, Ilya
    Graus, Francesc
    NEUROLOGY, 2024, 102 (07) : e208101